[Edaily Reporter Shin Ha-yeon ] NextEye Co., Ltd.(137940)is set to expand its cosmetics business by conducting a 1.9 billion won third-party private placement targeted at its largest shareholder.
NextEye Co., Ltd. announced on the 1st that it has decided to conduct a third-party private placement worth 1.9 billion won targeting its largest shareholder, AMPLE OCEAN LIMITED. Through this capital increase, the company will issue 1,275,168 new shares at 1,490 won per share. The payment date is set for the 9th, and the new shares are scheduled to be listed on the 30th of this month. The funds raised will be used as working capital to expand the cosmetics business of “ROADMIR,” a global business-to-consumer (B2C) e-commerce platform.
The company explained that the largest shareholder’s direct participation in the capital increase reaffirms their commitment to responsible management while bolstering the company’s competitiveness and corporate value. Following the listing of the new shares, the total number of issued shares will increase from the current 8,536,899 to 9,802,067.
Through its subsidiary ROADMIR Bio, NextEye Co., Ltd. distributes health functional foods and cosmetics to 11 countries, including China, Hong Kong, Taiwan, Canada, Vietnam, and Malaysia. According to internal figures, revenue for the first half of this year exceeded 120 billion won, already surpassing last year’s annual revenue (103 billion won).
The company plans to cultivate cosmetics as a new growth engine, following health functional foods, which currently account for about 90% of platform revenue. It intends to expand its cosmetics lineup—currently consisting of eight products—and increase the number of countries it operates in to up to 20 by the end of the year to strengthen its global market strategy.
A company official stated, “Through this rights offering, in which our largest shareholder is directly participating, we have secured the funds needed for the global expansion of the Roadmir platform,” adding, “We will proactively respond to the trend of stricter listing maintenance requirements and continue to enhance our overall business competitiveness.”
ABLE C&C(078520)is establishing a subsidiary in the Netherlands to serve as the control tower for its European operations. Following the establishment of its UK subsidiary, the company is setting up a…
On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
As global Big Pharma companies embark on large-scale mergers and acquisitions (M&A) to overcome the patent cliff and growth limitations, there are increasing instances of Chinese biotech companies bei…